SILO PHARMA, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
SILO PHARMA, INC. (SILO) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $13.66 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.66K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $52.84K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $109.46K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $137.28K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $13.66K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $52.84K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $109.46K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $137.28K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $150.12K 10-Q · filed 2025-08-13 |
| 2024-12-31 | $0.00 POS AM · filed 2026-04-14 |
| 2019-09-30 | $8.75K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $61.23K 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |